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1. Introduction 
The endothelium, the innermost layer of blood vessels, has many important biological 
functions which are responsible for regulating vascular tone and structure. One of the major 
functions of a healthy endothelium is to ensure adequate blood supply to the different 
tissues. This particular process is regulated by the release and interaction of different 
vasoactive substances (i.e. vasodilators and vasoconstrictors), which are under tight balance. 
On the other hand, it is well known that the chronic exposure to certain stresses (e.g. 
inflammation, oxidative stress, and hyperglycemia) promotes changes in the endothelium 
leading to endothelial dysfunction.  
Type 2 diabetes mellitus (T2DM) is among those chronic diseases that are associated with 
endothelial dysfunction which may contribute to limited glucose uptake in skeletal muscle. 
In fact, diabetes-related endothelial dysfunction has been reported to lead to morphologic 
and structural vascular changes present throughout the course of diabetes (Taylor and 
Poston, 1994). There are around 17 million people in the United States who have diabetes, of 
whom close to 95% have T2DM. Cardiovascular disease (CVD) is the major cause of 
morbidity and mortality in people with T2DM (Ness et al., 1999), and coronary heart disease 
is the most common cause of death among those individuals. For instance, people with 
T2DM are two to four times more likely to develop CVD compared with people without the 
condition (Stamler et al., 1993). 
Interestingly, physical activity is an important therapeutic tool to maintain endothelial 
function. In fact, regular physical exercise has been reported to be effective in the prevention 
and delay of onset of T2DM (Bassuk and Manson, 2005; Sanz et al., 2010; Stewart, 2002). 
Thus the primary purpose of this chapter is to summarize the current available literature 
concerning the effects of T2DM on arterial endothelium. In addition, this chapter is intended 
to summarize evidence of the beneficial effects of physical activity on the untoward 
cardiovascular effects of T2DM and/or the apparent ability of physical activity to prevent 
progression of diabetes-induced CVD. 
2. Vascular endothelial function  
2.1 Role of the endothelium in vasoregulation  
All blood vessels in the systemic and pulmonary circulations are lined by a continuous 
single cell layer of endothelium. This layer of endothelial cells continues throughout the 
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cardiac chambers as well. As a result of research over the past 30 years it is established that 
the endothelium constitutes a very important and exciting organ. The endothelium plays an 
important role in hemostasis, inflammation, lipid metabolism, vascular growth, cell 
migration, formation of (and interactions with) extracellular matrix molecules, as well as 
control of vascular permeability and vascular resistance (both vasodilator and 
vasoconstrictor responses) (Furchgott and Vanhoutte, 1989; Ganz and Vita, 2003). The 
endothelium can detect chemical substances within the blood and physical forces imparted 
to blood vessel walls (i.e. shear stress and distention) and initiate responses to these 
chemical and/or physical signals by releasing substances that modulate vascular tone 
and/or blood vessel structure (Adair et al., 1990; Furchgott and Vanhoutte, 1989). The 
vascular endothelium releases a variety of vasoactive substances, including vasodilator and 
vasoconstrictor substances such as endothelin, which contribute to vasomotor control in 
tissues throughout the body. As described below, the most common measure of the 
functional capacity of the endothelium is to measure endothelium-dependent dilation 
(EDD) primarily because of the potential to assess the health of the endothelium non-
invasively. Usually, EDD is the result of release of endothelium-derived relaxing factors 
(EDRFs). 
There appear to be at least three EDRF substances, two of which have been identified; 
prostacyclin (PGI2) and nitric oxide (NO) (Furchgott and Vanhoutte, 1989; Palmer et al., 
1988a; Palmer et al., 1987; Palmer et al., 1988b). The other EDRF, often referred to as 
endothelium-derived hyperpolarizing factor (EDHF) may not actually be a factor but 
perhaps represents electrical communication through the gap junctions between endothelial 
and vascular smooth muscle cells (Cohen and Vanhoutte, 1995; Feletou and Vanhoutte, 
2004; Fichtlscherer et al., 2004; Triggle et al., 2003). The relative importance of endothelium-
dependent control differs among the tissues of the body at least in part because the 
endothelial lining is not a homogeneous compartment. Rather the endothelium is 
characterized by significant structural and functional heterogeneity among tissues and 
within tissues (Aird, 2007a, b; Laughlin et al., 2008). Even within the vascular bed of a given 
skeletal muscle, the relative importance of endothelium-dependent vascular control 
mechanisms changes along the length of the arteriolar network (Laughlin et al., 2008; 
Laughlin et al., 2001; Laughlin et al., 2003; Laughlin et al., 2004). 
NO is produced in endothelial cells by endothelial nitric oxide synthase (eNOS) from L-
arginine and oxygen. In its role in vascular control, NO diffuses to the underlying smooth 
muscle cells, where it activates soluble guanylyl cyclase, resulting in production of cyclic 
guanosine monophosphate (cGMP) and activation of protein kinase G (PKG), which leads to 
vasodilation. eNOS is activated by phopshorylation stimulated by shear stress, chemical 
mediators, and/or by binding of calcium-calmodulin following increases in intracellular 
calcium signalled by mechanical forces (i.e. an increase in shear stress exerted by the blood 
flow on the endothelium, referred to as flow-induced dilation) and/or by a host of chemical 
factors (acetylcholine, bradykinin, substance P, noradrenaline)(Balligand et al., 2009; Barnes 
and Liu, 1995; Furchgott and Vanhoutte, 1989; Vanhoutte, 1989) acting on their respective 
receptors on the endothelium (Furchgott and Vanhoutte, 1989; Ganz and Vita, 2003). Flow-
induced dilation has been demonstrated in conduit and resistance arteries in various 
vascular beds (Drexler et al., 1989; Miura et al., 1999; Miura et al., 2001; Sinoway et al., 1989). 
The weight of evidence suggests that an increase in wall shear stress, secondary to the 
increased flow, is the physical force that initiates dilation (Pohl et al., 1991). Selective 
removal or destruction of the endothelium typically abolishes the response (Hull et al., 1986; 
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Lie et al., 1970; Rubanyi et al., 1986) implicating the production and/or release of 
endogenous, transferable vascular smooth muscle relaxing factor(s) from endothelial cells 
(Kuo et al., 1991).   
Prostanoid EDRFs are metabolites of arachidonic acid produced by the cyclooxygenase 
pathway. Arachidonic acid itself can produce vasoconstriction or vasodilation in some 
vascular beds such as the pulmonary vascular bed, depending on concentration and tone at 
the time of administration (Barnes and Liu, 1995; Furchgott and Vanhoutte, 1989; Vanhoutte, 
1989). These effects of arachidonic acid on the vasculature are largely due to formation of 
prostanoids and/or thromboxane A2 (Barnes and Liu, 1995; Furchgott and Vanhoutte, 1989; 
Palmer et al., 1988a; Palmer et al., 1987; Selig et al., 1986; Vanhoutte, 1989). There is evidence 
that the chemical identity of EDHF may vary across vascular beds (Laurindo et al., 1994; 
Miura et al., 2003; Sorop et al., 2003). The five leading candidates for the identity of EDHF 
include extracellular potassium (Edwards et al., 1998), hydrogen peroxide and/or 
superoxide anion, epoxygenase/cytochrome P450 metabolites, and electrical conduction of 
hyperpolarization through myoendothelial gap junctions (Feletou and Vanhoutte, 2004; 
Fichtlscherer et al., 2004; Fisslthaler et al., 1999; Triggle et al., 2003).  
Endothelins are vasoactive peptides produced by vascular endothelial cells (Korth et al., 
1999). Three different isoforms of endothelins (ET) have been identified, namely, ET-1, ET-2 
and ET-3 (Haynes and Webb, 1998; Masaki, 2004). ET-1 is the most abundant isoform 
expressed and secreted in endothelial cells and it is one of the most potent vasoconstrictor 
agents described to date (Haynes and Webb, 1998). ET-1 is constitutively released by 
endothelial cells with the majority (~80%) released luminally towards vascular smooth 
muscle (Wagner et al., 1992). Thus ET-1 appears to act primarily in a local paracrine, rather 
than circulating endocrine, manner. ET receptors are expressed on endothelial and vascular 
smooth muscle cells of both arteries and veins throughout the pulmonary and systemic 
vascular trees (Loesch, 2005; Rubanyi and Polokoff, 1994). Binding of ET to the Gq-protein 
coupled endothelin type A (ETA) and to endothelin type B (ETB) receptors on vascular 
smooth muscle leads to vasoconstriction whereas activation of ETB receptors on the 
endothelium leads to production of NO and prostacyclin, which induce vasodilation 
(Rubanyi and Polokoff, 1994; Schiffrin and Touyz, 1998; Webb and Haynes, 1995). Although 
the role of ET-1 in determination of regional blood flow remains unclear, it appears that ET-
1 contributes to the control of blood flow to the heart, lungs, kidneys, visceral organs and 
skeletal muscle but likely not to the brain under normal conditions (Koedel et al., 1998; 
Maeda et al., 2002; Merkus et al., 2003). Also, there is evidence that alterations in the ET-1 
system contribute to vascular dysfunction in T2DM (Lam, 2001; Schneider et al., 2007). 
2.2 Endothelial function assessment 
2.2.1 Non-invasive techniques 
These techniques are mainly used to evaluate the vasomotor response to physical and/or 
pharmacological stimuli of the endothelium. For instance, flow-mediated vasodilation 
(FMD), using ultrasonography, is the classic technique used to detect changes in superficial 
arteries (e.g. brachial, radial or femoral), allowing the measurement of blood flow, blood 
flow velocity and vascular diameter changes (Corretti et al., 1995). The vasodilatory 
response, after a period of transient ischemia (~ 5 min), is dependent upon a series of 
neurologic, myogenic and chemical intermediates, which includes the release of NO. There 
is a good correlation between this post-ischemic vasodilation observed in the forearm (i.e. 
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FMD) and the coronary vasodilation caused by acetylcholine (Anderson et al., 1995). Thus 
FMD is used as a surrogate of endothelial health. In addition, strain gauge plethysmography 
is also used to determine blood flow.  
2.2.2 Invasive in vivo techniques 
These techniques are used to evaluate endothelial function of arteries and to determine the 
probable changes in their diameter, by ultrasonograhpy, or blood flow, by 
plethysmography, after cardiac catheterization to access the coronary circulation. These 
methods allow also the intra-arterial infusion of different drugs and/or neurohumoral 
factors to study the endothelial-dependent or independent properties. Finally, it is worth 
noting that the use of in vitro direct methods. For instance, cell culture allows the evaluation 
of the different vasoactive substances that can be secreted by the endothelium in response to 
changes in blood flow and/or shear stress (Malek et al., 1999). Isolated arteries, from 
different vascular beds, can be used to determine the specific responses to diverse 
endothelial-dependent dilators and/or inhibitors (Luscher and Noll, 1996). 
3. Link between endothelial dysfunction and T2DM: Pathophysiology 
3.1 Vascular inflammation 
Endothelial dysfunction is characterized by a chronic, systemic pro-inflammatory state, 
reduced vasodilation (reduction in relaxing factors and an increase in contracting factors), 
and a pro-thrombotic state. T2DM is among the multiple diseases and conditions that are 
initiated or associated with endothelial dysfunction (Beckman et al., 2003; Laight et al., 1999; 
Schofield et al., 2002). In fact, it has been suggested that endothelial dysfunction is an 
important factor in the pathogenesis of vascular disease observed in patients with diabetes 
(De Caterina, 2000; Schalkwijk and Stehouwer, 2005). There is evidence that inflammatory 
states are associated with T2DM, obesity, and insulin resistance (Hotamisligil et al., 1993; 
Lehrke and Lazar, 2004). 
The plasma concentrations of C-reactive protein (CRP), fibrinogen, interleukin-6, 
interleukin-1, and tumor necrosis factor alpha (TNFα) are increased in diabetes (Grau et al., 
1996; Shurtz-Swirski et al., 2001). Hotamisligil et al. (Hotamisligil et al., 1993) reported that 
the expression of TNFα, a pro-inflammatory cytokine, was markedly increased in obese 
mice; and when TNFα was counterbalanced insulin resistance improved. Interestingly, the 
increased levels of CRP would mediate opposite actions on the vasculature. It promotes the 
increase of adhesion molecules (intracellular adhesion molecule; ICAM-1, vascular cell 
adhesion molecule; VCAM-1), E-selectin, monocyte chemotactic protein-1 (MCP-1), and ET-
1. On the other hand it decreases eNOS expression, NO and prostacyclin bioavailability, and 
elevates the expression of angiotensin receptor type 1 in the vessel wall (Pasceri et al., 2000; 
Schalkwijk and Stehouwer, 2005; Venugopal et al., 2002). Insulin exerts anti-inflammatory 
effects at the cellular and molecular levels in vitro and in vivo. It has been shown that low-
dose infusion of insulin reduces reactive oxygen species generation, and suppresses 
NADPH oxidase expression and plasma ICAM-1 and MCP-1 concentrations. Conversely, 
long-term insulin infusion (~ 4 hours) in healthy subjects was associated with an induction 
of endothelial dysfunction (Hartge et al., 2006). 
Clearly, the increased levels of these inflammatory cytokines resulted in increased vascular 
permeability, change in the vasoregulatory responses, and increase in the adhesion of 
leucokytes to the endothelium. The diabetes-associated alterations on the endothelium that 
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lead to endothelial dysfunction can be summarized as follows; a) impairment of NO 
production and/or bioavailability, b) reduced NO responsiveness, c) elevated expression 
and plasma levels of different vasoconstrictors, d) increased adhesion molecule expression, 
and e) associated enhanced adhesion of vascular cells (e.g. platelets and monocytes) to the 
endothelium.  
3.2 The metabolic syndrome: Obesity and cardiovascular disease 
The metabolic syndrome is a collection of risk factors for CVD, typically characterized by 
endothelial dysfunction. Metabolic syndrome is diagnosed if there are three of the five 
following components; a) increased abdominal adiposity, b) atherogenic dyslipidemia, c) 
elevated blood pressure, d) insulin resistance and/or glucose intolerance (i.e. T2DM), and e) 
a proinflammatory and prothrombotic state (Grundy et al., 2005; Kahn et al., 2005). 
Incidence of metabolic syndrome has been on the rise over the last decade both in the 
United States (Ford et al., 2002; Park et al., 2003) and world-wide (Gupta et al., 2004; Magi et 
al., 2005). Individuals with identified metabolic syndrome are at increased risk for CVD 
(Malik et al., 2004; Mottillo et al., ; Wilson et al., 2005), an observation independent of age 
(Ferreira et al., 2007; Lakka et al., 2002; McNeill et al., 2006). The key findings of these 
studies were that metabolic syndrome leads to a 2-fold increase in CVD and a 1.5-fold 
increase in all-cause mortality (Mottillo et al.), that increased risk for CVD is not gender 
specific (Wilson et al., 2005), and that children with metabolic syndrome possess high levels 
of multiple risk factors (e.g. hypertension, dyslipidemia, and glucose intolerance) for CVD 
(Ferreira et al., 2007; Taha et al., 2009).  
Obesity and/or adipose tissue disorders are also recognized as a potential primary 
etiological origin for metabolic syndrome. However, independent of the metabolic 
syndrome, obesity has been increasing in incidence in both adults and children (Klein et al., 
2004; Poirier et al., 2006), and is a risk factor for CVD (Hubert et al., 1983; Larsson et al., 
1984). It is also well established that metabolic syndrome and obesity linked with metabolic 
syndrome promote endothelial dysfunction in adults and children (Aggoun, 2007; Singhal, 
2005). More current studies over obesity have elucidated that adipose tissue is not just a 
simple reservoir for energy storage and thermoregulation but rather a complex, 
indispensable, active metabolic and endocrine organ (Rosito et al., 2008; Sacks and Fain, 
2007). Recent studies have demonstrated that adipose tissue possesses the potential to 
undergo a phenotypic switch in inflammatory and obese-like environments leading it to 
secrete “adipokines” that increase risk for CVD (Chatterjee et al., 2009; Payne et al., 2010; 
Sacks and Fain, 2007) and negatively impact endothelial function (Bunker and Laughlin, 
2010; Ketonen et al., 2010; Ma et al., 2010; Payne et al., 2009).  
3.3 Insulin resistance 
In addition to possessing metabolic actions, it is also established that insulin exerts influence 
over vascular function via; a) stimulation NO production from endothelium, leading to 
vasodilation; b) increased skeletal muscle blood flow; and c) augmentation of glucose 
disposal in skeletal muscle (Baron and Clark, 1997). Insulin resistance is typically defined as 
decreased responsiveness to insulin’s actions that stimulate glucose uptake in the tissues 
(Lebovitz, 2001). Endothelial dysfunction and insulin resistance often co-exist, however at 
present it remains unclear as to which one leads to/causes the other. A key characteristic of 
T2DM, insulin resistance is also an independent risk factor for endothelial dysfunction 
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associated with various forms of CVD (Arcaro et al., 2002; Campia et al., 2004; Williams et 
al., 1996). Cross-sectional studies indicate endothelial dysfunction can independently predict 
incidence of insulin resistance/diabetes in humans (Meigs et al., 2004; Meigs et al., 2006; 
Thorand et al., 2006). Additionally, studies examining rodent models of endothelial 
dysfunction have demonstrated that even partial defects in endothelial function are 
sufficient to cause insulin resistance (Cook et al., 2004; Duplain et al., 2001). Taken together 
current evidence supports a causal role for endothelial dysfunction in the development of 
insulin resistance. 
On the other hand a very recent study, the Women's Health Initiative Observational Study 
(WHIOS), was conducted calling into question the utility of using endothelial dysfunction 
biomarkers for insulin resistance and T2DM prediction (Chao et al., 2010). The WHIOS 
involved 1,584 incident T2DM cases and 2,198 matched controls to evaluate the utility of 
plasma markers of inflammation and endothelial dysfunction for T2DM risk prediction. 
Results indicated that none of the inflammatory and endothelial dysfunction markers 
improved T2DM prediction in a multiethnic cohort of postmenopausal women. Other recent 
studies have also shown that in humans with insulin resistance, a subsequent impairment 
occurs in insulin’s ability to induce endothelium dependent vasodilation that is dramatically 
improved with insulin therapy (Franklin et al., 2008; Rask-Madsen et al., 2001; Vehkavaara 
et al., 2000). It was also demonstrated recently in rat model of T2DM that insulin resistance 
manifested prior to a dramatic (20-35%) progressive decline in endothelial function 
concurrent with T2DM disease development (Bunker et al., 2010). Collectively these studies 
suggest a potential causal role of insulin resistance in the development of endothelial 
dysfunction. 
Whichever pathology manifests first, endothelial dysfunction or insulin resistance, it is 
demonstrably clear that development of either pathology rarely occurs without the 
subsequent development of the other pathology. 
3.4 Hyperglycemia 
Generally speaking, hyperglycemia can be divided into two broad categories; a) impaired 
fasting glucose, and b) impaired glucose tolerance. The latter is commonly characterized by 
2-hour post-prandial hyperglycemic spikes of 140mg/dl to ≥200mg/dl (Node and Inoue, 
2009). These post-prandial spikes in plasma glucose are known to contribute to endothelial 
dysfunction and CVD in humans, independent of the metabolic syndrome (Ceriello et al., 
2002; Su et al., 2008; Title et al., 2000). Indeed, hyperglycemia is the major causal factor in the 
development of endothelial dysfunction in diabetes. Results from these studies and many 
others suggest that endothelial dysfunction is mediated through mechanisms that primarily 
involve generation of oxidative stress that subsequently lowers NO bioavailability. 
Impaired fasting glucose is defined by an elevated fasting plasma glucose concentration of 
≥100mg/dl and <126 mg/dl (Genuth et al., 2003), which is also an indication of chronically 
elevated plasma glucose levels. Evidence from recent human studies suggests that fasting 
hyperglycemia, independent of diabetes and the metabolic syndrome, contributes to 
endothelial dysfunction and CVD (Rodriguez et al., 2005; Su et al., 2008). However, evidence 
is slowly mounting from human and animal studies that suggest oscillating glucose levels 
seen with impaired glucose tolerance can have more deleterious effects than the constant 
high glucose levels seen with impaired fasting glucose on endothelial function and oxidative 
stress (Ceriello et al., 2008; Horvath et al., 2009; Monnier et al., 2006). 
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3.5 Oxidative stress 
Elevated production of reactive oxide species (ROS) has been implicated in the development 
of T2DM (Avogaro et al., 2006; Irani, 2000; Liu et al., 2005; Tesfamariam and Cohen, 1992; 
Yang et al., 2010). The molecular basis for excessive mitochondrial ROS in diabetes has been 
extensively reviewed elsewhere (Irani, 2000; Yang et al., 2010; Avogaro et al., 2006). These 
free radicals also play a critical role in the pathogenesis of diabetes-associated vascular 
complications (macro-and microangiopathy) (Giugliano et al., 1996; Spitaler and Graier, 
2002). In T2DM, the endothelium, due to glucose oxidation, promotes the increase of free 
radicals (e.g. superoxide and hydrogen peroxide) leading to enhanced intracellular 
production of hydroxyl radical which has been linked to diabetes-induced endothelial 
dysfunction (Giugliano et al., 1996; Pieper et al., 1997; Shi and Vanhoutte, 2009; Spitaler and 
Graier, 2002; Tesfamariam and Cohen, 1992). In that regard, animal models of diabetes have 
been associated not only with reduced NO bioavailability but also with impaired EDD 
(Durante et al., 1988; Rosen et al., 1995; Tesfamariam, 1994) as the result of the 
hyperproduction of superoxide and hydrogen peroxide. In addition, there is evidence that 
indicates that increased ROS plays an important role in the development of diabetic 
complications. Maejima et al. (Maejima et al., 2001) reported that the decrease EDD observed 
in patients with T2DM is linked to NO inactivation resulting from increased oxidative stress, 
and that abnormal NO metabolism is related to advanced diabetic microvascular 
complications. Furthermore, endothelial cells in patients with T2DM are not able to produce 
sufficient amount of NO and therefore fail to vasodilate in response to vasodilators (e.g. 
acetylcholine, bradykinin, shear stress) (Avogaro et al., 2006).  
The increased glucose levels (“hyperglycemia”) also promote mitochondrial formation of 
ROS. It has been reported that in aortic endothelial cells hyperglycemia induced increased 
superoxide production which prevents eNOS activity and expression (Srinivasan et al., 
2004). The formation of peroxynitrite (superoxide and NO interaction) promotes blunted 
NO-mediated vasodilatory response and further induces cellular damage through 
depletion of tetrahydrobiopterin (BH4), an important co-factor for eNOS activity 
(Pannirselvam et al., 2002). In addition, there are reports indicating that glucose 
variability (“intermittent low and high glucose levels”) is associated with an excessive 
production of ROS (Monnier et al., 2006; Piconi et al., 2004) which promotes even more 
detrimental effects to the endothelium (Ceriello et al., 2008; Piconi et al., 2004). Shi et al. 
(Shi et al., 2007; Shi and Vanhoutte, 2009) reported that elevated levels of ROS not only 
reduce NO bioavailability, but also facilitate the production and/or action of EDCFs in 
the course of T2DM. Finally, the augmented production of ROS in T2DM can also 
promote the inactivation of antioxidant proteins and therefore reduce the antioxidant 
defense mechanisms (Laight et al., 1999; Shi et al., 2007). 
3.6 Dyslipidemia  
T2DM promotes elevated total cholesterol, high levels of oxidized lipoproteins, especially 
low density lipoptotein (LDL), high triglycerides levels, and decreased high-density 
lipoprotein (HDL) (Watkins, 2003). It has been suggested that abnormal lipids and 
lipoproteins play a role in endothelial dysfunction in T2DM (McVeigh et al., 1992). For 
instance, endothelium-dependent vasodilation was negatively and significantly correlated 
with elevated triglyceride, LDL and low HDL cholesterol concentrations (Watts et al., 1996). 
In the same manner, it has been shown that only LDL size was inversely correlated with the 
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acetylcholine-induced brachial EDD (Makimattila et al., 1999). Clearly, we can infer from the 
above studies that LDL is one of the chief factors involved in endothelial dysfunction.  
LDL and other lipoproteins are able to cross the endothelial cells layer by vascular transport, 
and later they are oxidatively modified at the sub-endothelial space into reactive oxygen 
species generated by macrophages, endothelial cells and smooth muscles (Steinberg, 1997). 
The accumulation of oxidized-LDL is toxic to endothelial cells, which in turn alters the 
function and structure of the endothelium (McVeigh et al., 1992; Tribe and Poston, 1996). 
Oxidized-LDL decreases NO production by reduction of NOS (Tribe and Poston, 1996) or by 
stimulating the synthesis of caveolin-I (Bist et al., 1997), consequently contributing to 
defective vasodilatation. In addition, there are indications that oxidized-LDL could also 
enhance the release of ET-1, a main endothelial constrictor peptide (Boulanger et al., 1992).  
3.7 Mechanisms of endothelial dysfunction in T2DM 
Over 170 million people in the world were affected by diabetes in 2000 and this is expected 
to increase to over 360 million by the year 2030 (Bakker et al., 2009; Ostergard et al., 2007). 
Type 1 diabetes is characterized by an absence of insulin while T2DM is characterized by 
insulin resistance followed in time with decreased plasma insulin. Vascular disease is the 
major cause of death in individuals with T2DM. The vascular complications of T2DM take 
two major forms; a) atherosclerosis in conduit arteries and b) microvascular dysfunction in 
skeletal muscle vascular beds. The vasodilatory effects of insulin account for up to 40% of 
insulin-mediated glucose disposal in skeletal muscle following a meal. In obesity and 
T2DM, the vasodilatory action of insulin is impaired. Insulin-stimulated NO production via 
the insulin-receptor substrate-1 (IRS-1) pathway is diminished, while vasoconstriction 
through the mitogen-activated protein kinase (MAPK) pathway, endothelin-converting 
enzyme (ECE) and subsequent secretion of the vasoconstrictor ET-1 may be augmented. As 
a result, microvascular blood flow and delivery of glucose to muscle tissue are diminished, 
contributing to reduced skeletal muscle glucose uptake and peripheral insulin resistance. 
Insulin resistance in T2DM appears to be the result of abnormal insulin-induced glucose 
uptake by skeletal muscle and microvascular dysfunction in skeletal muscle (blunted 
insulin-induced vasodilation).  
Control of blood flow to skeletal muscle is abnormal in diabetes as muscle blood flow is less 
than normal during exercise in forearms of obese women (Hodnett and Hester, 2007), obese 
children (Ribeiro et al., 2005), in legs of diabetes subjects during cycle exercise (Hodnett and 
Hester, 2007; Kingwell et al., 2003), and in obese Zucker rats (Frisbee, 2003; Frisbee et al., 
2006; Xiang et al., 2005). The abnormal control of vascular resistance in diabetes is associated 
with decreased arterial compliance, decreased microvascular density, altered smooth muscle 
dependent vascular reactivity and endothelial dysfunction (Frisbee et al., 2006; Hodnett and 
Hester, 2007). Local metabolic control of blood flow is abnormal and myogenic control of 
vascular smooth muscle tone is affected in diabetes as well. For instance, arterioles isolated 
from obese Zucker rat skeletal muscle exhibit increased spontaneous tone due to changes in 
vascular smooth muscle and to changes in an endothelium-derived factor (Frisbee et al., 
2006). The endothelium of both conduit arteries and resistance arteries is dysfunctional in 
diabetes (Hodnett and Hester, 2007).  Endothelial dysfunction in conduit arteries appears to 
be associated with decreased bio-availability of NO with sustained (or normal) eNOS 
content, decreased phospho-eNOS, deceased BH4 and cytochrome P450 expression as well 
as increased thromboxane (TXA2) content. In the conduit arteries, endothelial dysfunction is 
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believed to contribute to development of atherosclerosis while in the resistance arteries 
endothelial dysfunction leads to disruptions in the control of blood flow as well as blunted 
angiogenesis and structural vascular remodeling (rarefaction)(Frisbee et al., 2006). In normal 
skeletal muscle insulin-mediated EDD-induced increases in blood flow are responsible for 
25-50 % of the increase in glucose clearance stimulated by insulin administration (Kim et al., 
2006). Thus, it appears that endothelial dysfunction of resistance arteries in muscle tissue 
includes blunted insulin-stimulated vasodilation (Mikus et al., 2010).  
Endothelial dysfunction in T2DM is associated with glucotoxicity, lipotoxicity, and 
inflammation which impair insulin signaling (i.e. endothelial cell insulin resistance).  These 
effects may be the result of cytokine signaling and/or increased ROS in the arteries. There 
are at least two sources of ROS believed to cause endothelial dysfunction in diabetes; a) 
hyperglycemia, and b) vascular inflammation (Kim et al., 2006; Luscher and Steffel, 2008). 
Kim et al (Kim et al., 2007) concluded that nutrient excess (excess glucose/lipid) stimulates 
cellular inflammatory responses that produce insulin resistance leading to decreased Akt 
and eNOS phosphorylation and increased NF-kB expression leading to expression of 
inflammatory cytokines in endothelial cells. For instance, Romero et al. (Romero et al., 2008) 
concluded that hyperglycemia plays a key role in increasing ROS in diabetes through 
stimulation of arginase activity/expresson in vascular cells. Insulin binding to its receptor 
signals through two distinct pathways in endothelial cells; a) activation of the IRS-
1/phosphatidylinositol 3-kinase (PI3-kinase)/phosphor- Akt/phosphor-eNOS causing 
release of NO and EDD; b) increased release of ET-1through the mitogen-activated protein 
kinase (MAPK) pathway. Evidence indicates that T2DM produces an imbalance in the 
production of NO and ET-1 in response to insulin so that ET-1 release is up-regulated (Kim 
et al., 2006). It appears that when endothelium is insulin resistant, due to blunted signaling 
through the IRS-1/Akt/p-eNOS signaling pathway, ET-1 induced constriction leads to 
decreased muscle blood flow during insulin stimulation (Eringa et al., 2007).  
4. Physical activity and type 2 diabetes: Focus on the endothelium 
4.1 Benefits of physical activity 
Physical activity may be beneficial in slowing the initiation and progression of T2DM and its 
cardiovascular sequelae through favorable effects on body weight, insulin sensitivity, 
glycemic control, blood pressure, lipid profile, fibrinolysis, inflammatory defense systems, 
and endothelial function. More comprehensive reviews regarding the beneficial effects 
and/or recommendations of physical activity in patients with T2DM have been previously 
published (Bassuk and Manson, 2005; Sanz et al., 2010; Stewart, 2002; Colberg, 2010). The 
following section is intended to present the available evidence of the beneficial effects of 
physical activity focusing on endothelial function. For instance, in clinical trials of patients 
with diabetes, physical activity (e.g. aerobic exercise) has been shown to increase vasodilator 
bioavailability (e.g. NO and prostacyclin) and to improve EDD (Moyna and Thompson, 
2004; Roberts et al., 2002). 
4.2 Acute effects of exercise 
4.2.1 Aerobic exercise 
Studies examining the acute effects of aerobic exercise training on endothelial function in 
T2DM are somewhat limited. A series of experiments examining the effects of a single bout 
of maximal (Colberg et al., 2003) and moderate (Colberg et al., 2006b) aerobic cycling 
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exercise training found that baseline skin blood flow following local heating significantly 
increased following the exercise in subjects with T2DM (Colberg et al., 2003; Colberg et al., 
2006b) and that this effect was independent of interstitial subcutaneous NO levels (Colberg 
et al., 2006b). 
A study by Kingwell et al. (Kingwell et al., 2003) demonstrated that leg blood flow during 
aerobic cycling exercise and in response to acetylcholine infusion was significantly impaired 
in T2DM. Infusions of sodium nitroprusside were not different between diabetic subjects 
and weight-matched controls, suggesting that the impaired leg blood flow during aerobic 
exercise in T2DM was a result of endothelial dysfunction. 
4.2.2 Resistance exercise 
Even more limited are studies examining the acute effects of resistance exercise training on 
endothelial function in T2DM. Currently only one study has examined the acute effects of 
resistance exercise training on endothelial function in subjects with T2DM. Indeed, Colberg 
et al. (Colberg et al., 2006a) investigated whether 8-weeks of cycle-ergometery resistance 
exercise would affect cutaneous perfusion following local heating in T2DM subjects. Their 
results indicated that resistance exercise training does not significantly affect cutaneous 
perfusion, either at baseline or following local heating. This finding was independent of 
unchanged interstitial NO levels. More studies are needed in this area for a better 
understanding of how resistance exercise training affects the endothelium in T2DM.  
4.3 Chronic effects of exercise training 
4.3.1 Aerobic exercise 
Very few studies exist examining the effects of chronic aerobic exercise training alone on 
endothelial function in T2DM. A positive association between aerobic status, skin blood 
flow, and endothelial function has been demonstrated in patients with T2DM (Colberg et al., 
2002); however further studies from this same group revealed that 10 weeks of aerobic 
exercise training intervention does not improve impaired cutaneous perfusion (i.e. 
endothelial function) in patients with T2DM (Colberg et al., 2005).  
Several human studies exist examining the combined effects of chronic aerobic and 
resistance exercise training on endothelial function in T2DM, but yield conflicting results. 
For instance, Mairoana et al. (Maiorana et al., 2001) found that 8 weeks of combined aerobic 
and resistance exercise training exerted a significant positive effect on conduit (i.e. brachial 
artery FMD) and resistance artery (i.e. forearm plethysmography) endothelial function in 
patients with diagnosed T2DM.  Okada et al. (Okada et al., 2010) also found very recently 
that 3 months of combined chronic aerobic and resistance exercise training improved 
brachial FMD in patients with T2DM.  
However, the study by Miche et al. (Miche et al., 2006) found that 4 weeks of combined 
aerobic and resistance exercise training had no effect on brachial artery endothelial function 
in patients with severe T2DM. Lastly Middlebrooke et al. (Middlebrooke et al., 2006) 
demonstrated in elderly patients with T2DM (60+ years of age) that 6 months of regular 
aerobic exercise training does not improve microvascular function (i.e. skin blood flow) or 
aerobic fitness. It should be noted that the patients in the Colberg et al. (Colberg et al., 2005), 
Miche et al. (Miche et al., 2006), and Middlebrooke et al. (Middlebrooke et al., 2006) studies 
had numerous other co-morbidities in addition to T2DM, thereby underscoring the 
importance of starting exercise training programs before the disease manifests into a 
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complex, multidimensional condition that is difficult to treat. Further studies in humans are 
needed at this time to know whether chronic aerobic exercise training alone exerts beneficial 
effects on endothelial function during T2DM.   
Current studies using the Otsuka Long-Evans Tokushima Fatty (OLETF) rat model of T2DM 
and obesity have revealed that chronic aerobic exercise training alone maintains endothelial 
function in conduit (i.e. aortic EDD) (Bunker et al., 2010) and resistance arteries (i.e. skeletal 
muscle arterioles) (Mikus et al., 2010) during the progression of T2DM. Other OLETF studies 
demonstrated the positive effect of chronic aerobic exercise training alone as a preventative 
measure for endothelial function (thoracic aorta and mesentery artery EDD) at single time-
points during T2DM progression (Minami et al., 2002; Sakamoto et al., 1998). It is worth 
noting that the experimental design of the OLETF studies was such that aerobic exercise 
training served as a preventative measure for endothelial dysfunction associated with 
T2DM, whereas in the human studies discussed above it served as an interventional 
measure for endothelial dysfunction associated with T2DM. The findings thus far from long-
term studies of aerobic exercise training alone collectively suggest that alterations in 
vascular NO bioavailability, due to direct or indirect changes in eNOS activity/expression, 
are contributing in part to endothelial dysfunction associated with T2DM.   
4.3.2 Resistance exercise 
The effects of chronic resistance exercise training on endothelial function are equally unclear 
at present. Chronic resistance exercise training alone has been shown to have little to no 
effect on skin blood flow and endothelial function in patients with T2DM (Colberg et al., 
2006a). This study observed in ten individuals with T2DM and nine similar non-diabetic 
controls that 8 weeks of moderate-intensity resistance training did not enhance baseline skin 
blood perfusion or interstitial NO levels. Results from this study are in agreement with the 
studies by Miche et al. (Miche et al., 2006) and Middlebrooke et al. (Middlebrooke et al., 
2006), discussed in the previous section (i.e. aerobic exercise), which showed that combined 
aerobic and resistance exercise training had no effect on endothelial function in T2DM. 
However they conflict with a recent study conducted by Cohen et al. (Cohen et al., 2008) 
where 14-months of resistance exercise training alone significantly improved endothelial 
function in the skin of men and women with diagnosed T2DM. They also conflict with the  
Mairoana et al. (Maiorana et al., 2001) and Okada et al. (Okada et al., 2010) studies, 
discussed in the previous section, where combined aerobic and resistance exercise training 
was found to positively influence endothelial function in T2DM. At present it remains very 
unclear as to the effect of chronic resistance exercise training alone on endothelial function 
in T2DM and more studies are warranted in this area. 
4.4 Physical activity: Mechanisms for its vascular benefits 
The mechanisms responsible for the beneficial effects of physical activity on endothelium in 
T2DM are under intense investigation at this time. As for other forms of CVD, it is possible 
that exercise has beneficial effects on endothelial function directly due to the effects of shear 
stress or other hemodynamic effects of each exercise bout on the vascular wall or through 
effects of physical activity on systemic risk factors. For instance, exercise bouts influence 
circulating cytokines released by skeletal muscle and adipose tissues and can alter 
circulating lipid profiles. However, most in the field seem to consider that physical activity 
positively impacts the vascular wall directly via episodic increases in shear stress and 
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indirectly via reduction of comorbidities often associated with insulin resistance (i.e., 
hyperglycemia, hypercholesterolemia) (Joyner and Green, 2009).  
It is known that endurance and interval sprint training enhance vascular function of the 
gastrocnemius, but not soleus, vasculature of healthy animals (Laughlin et al., 2004; 
McAllister, 2005) and that daily wheel running is sufficient to prevent the declines/changes 
in endothelial function associated with insulin resistance in feed arteries of skeletal muscles 
but effects in the aorta are less clear (Bunker et al, 2010). Physical activity also sustains 
insulin induced EDD (Mikus et al, 2010). Beneficial effects could also be the result of 
exercise-induced improvements in antioxidant systems in the vascular cells of the arteries, 
either endothelium or smooth muscle. It is important for research to establish the exact 
mechanisms so that exercise protocols can be designed to maximize these benefits.  
 
 
Fig. 1. Factors that participated in the pathogenesis of endothelial dysfunction in T2DM. 
NO; nitric oxide, ROS; reactive oxygen species. 
5. Conclusion 
Clearly, the information presented in this chapter emphasizes the major role of endothelial 
dysfunction in the development and/or progression of T2DM. However, the relationship of 
endothelial dysfunction and the many independent factors associated with T2DM (e.g. 
hyperglycemia, inflammation, hyperlipidemia, oxidative stress, insulin resistance, 
hypertension, obesity), presented in figure 1, is not completely understood. Furthermore, 
the precise mechanisms responsible for the beneficial effects of physical activity on the 
endothelium of individuals with T2DM are still under intense investigation. Obviously, 
more research is needed in this area, but we could speculate that the beneficial effects of 
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exercise on endothelial function are due to the effects of shear stress and/or other 
hemodynamic effects acting directly on the vascular wall or through effects of physical 
activity on systemic risk factors. 
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